Testing effectiveness (Phase 2)Ended earlyNCT03007719
What this trial is testing
Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1
Who this might be right for
Bladder Cancer
Lawrence Fong 4